Cargando…

The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease that leads to chronic inflammation of synovial tissue, ultimately causing joint damage, disability, and premature mortality. The peptidylarginine deiminase (PAD) family of proteins is involved in the production of anticitrullinated peptide an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciesla, Marek, Kolarz, Bogdan, Darmochwal-Kolarz, Dorota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279283/
https://www.ncbi.nlm.nih.gov/pubmed/35831381
http://dx.doi.org/10.1038/s41598-022-15726-1
_version_ 1784746361931956224
author Ciesla, Marek
Kolarz, Bogdan
Darmochwal-Kolarz, Dorota
author_facet Ciesla, Marek
Kolarz, Bogdan
Darmochwal-Kolarz, Dorota
author_sort Ciesla, Marek
collection PubMed
description Rheumatoid arthritis (RA) is a chronic autoimmune disease that leads to chronic inflammation of synovial tissue, ultimately causing joint damage, disability, and premature mortality. The peptidylarginine deiminase (PAD) family of proteins is involved in the production of anticitrullinated peptide antibodies (ACPA), which are clinically relevant markers of RA. ACPA recognizes citrullinated proteins generated mainly by PAD4. Polymorphisms of the PADI4 gene have been associated with RA in Asian populations, but in Europeans these associations are still difficult to estimate. A total of 147 subjects, 122 patients with RA, 52 ± 12.3 aged, 84.4% women and 25 healthy controls, 53 ± 8.4 aged, 72% women were enrolled in the study. Two single nucleotide polymorphisms (SNPs) of the PADI4 gene (PADI4_94, rs2240340 and PADI4_104, rs1748033) were genotyped using a real-time polymerase chain reaction. Genetic models (co-dominant-1 and 2, dominant, over-dominant, and recessive) were applied to find the associations between genotypes and ACPA as well as PAD4 antibodies (anti-PAD4) levels. We found no relationship between the distribution of genotypes in different genetic models and the levels of anti-PAD4, ACPA and RF antibodies. There were also no differences with respect to the haplotypes. Genetic variants PADI4_94 and PADI4_104 may not be clinically relevant as prognostic factors in patients with established RA.
format Online
Article
Text
id pubmed-9279283
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-92792832022-07-15 The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis Ciesla, Marek Kolarz, Bogdan Darmochwal-Kolarz, Dorota Sci Rep Article Rheumatoid arthritis (RA) is a chronic autoimmune disease that leads to chronic inflammation of synovial tissue, ultimately causing joint damage, disability, and premature mortality. The peptidylarginine deiminase (PAD) family of proteins is involved in the production of anticitrullinated peptide antibodies (ACPA), which are clinically relevant markers of RA. ACPA recognizes citrullinated proteins generated mainly by PAD4. Polymorphisms of the PADI4 gene have been associated with RA in Asian populations, but in Europeans these associations are still difficult to estimate. A total of 147 subjects, 122 patients with RA, 52 ± 12.3 aged, 84.4% women and 25 healthy controls, 53 ± 8.4 aged, 72% women were enrolled in the study. Two single nucleotide polymorphisms (SNPs) of the PADI4 gene (PADI4_94, rs2240340 and PADI4_104, rs1748033) were genotyped using a real-time polymerase chain reaction. Genetic models (co-dominant-1 and 2, dominant, over-dominant, and recessive) were applied to find the associations between genotypes and ACPA as well as PAD4 antibodies (anti-PAD4) levels. We found no relationship between the distribution of genotypes in different genetic models and the levels of anti-PAD4, ACPA and RF antibodies. There were also no differences with respect to the haplotypes. Genetic variants PADI4_94 and PADI4_104 may not be clinically relevant as prognostic factors in patients with established RA. Nature Publishing Group UK 2022-07-13 /pmc/articles/PMC9279283/ /pubmed/35831381 http://dx.doi.org/10.1038/s41598-022-15726-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Ciesla, Marek
Kolarz, Bogdan
Darmochwal-Kolarz, Dorota
The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis
title The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis
title_full The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis
title_fullStr The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis
title_full_unstemmed The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis
title_short The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis
title_sort lack of association between padi4_94 or padi4_104 polymorphisms and rf, acpa and anti-pad4 in patients with rheumatoid arthritis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279283/
https://www.ncbi.nlm.nih.gov/pubmed/35831381
http://dx.doi.org/10.1038/s41598-022-15726-1
work_keys_str_mv AT cieslamarek thelackofassociationbetweenpadi494orpadi4104polymorphismsandrfacpaandantipad4inpatientswithrheumatoidarthritis
AT kolarzbogdan thelackofassociationbetweenpadi494orpadi4104polymorphismsandrfacpaandantipad4inpatientswithrheumatoidarthritis
AT darmochwalkolarzdorota thelackofassociationbetweenpadi494orpadi4104polymorphismsandrfacpaandantipad4inpatientswithrheumatoidarthritis
AT cieslamarek lackofassociationbetweenpadi494orpadi4104polymorphismsandrfacpaandantipad4inpatientswithrheumatoidarthritis
AT kolarzbogdan lackofassociationbetweenpadi494orpadi4104polymorphismsandrfacpaandantipad4inpatientswithrheumatoidarthritis
AT darmochwalkolarzdorota lackofassociationbetweenpadi494orpadi4104polymorphismsandrfacpaandantipad4inpatientswithrheumatoidarthritis